Health Care·Pharmaceuticals·$2.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.38 | N/A | -11.63% |
management commentary, guidance changes, and full analysis available with Pro.
| -11.63% |
Tone: Defensive
Overall, management expressed caution regarding current market conditions. They remain committed to their strategic initiatives.
Management acknowledged the challenges faced in the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.
Phibro Animal Health reported a lower-than-expected EPS for the quarter, which typically raises concerns among investors. However, the stock reacted positively, increasing by 1.51%. This may indicate that investors are optimistic about the company's long-term strategy despite the EPS miss.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
WEYERHAEUSER CO REIT
May 6, 2016